A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2093-3371
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics ; volume:12 ; number:1 ; day:11 ; month:6 ; year:2021 ; pages:1-8 ; date:12.2021
Journal of analytical science and technology ; 12, Heft 1 (11.6.2021), 1-8, 12.2021
- Creator
-
Hegde, Aswathi R.
Padya, Bharat Singh
Soman, Soji
Mutalik, Srinivas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40543-021-00276-4
- URN
-
urn:nbn:de:101:1-2021100308225934210132
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hegde, Aswathi R.
- Padya, Bharat Singh
- Soman, Soji
- Mutalik, Srinivas
- SpringerLink (Online service)
Other Objects (12)
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
The early days of letrozole
A decade of letrozole: FACE
Letrozole in Male Breast Cancer
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
Letrozole in the extended adjuvant setting: MA.17
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
Letrozole sensitizes breast cancer cells to ionizing radiation
The discovery and mechanism of action of letrozole
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
The early days of letrozole
A decade of letrozole: FACE
Letrozole in Male Breast Cancer
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
Letrozole in the extended adjuvant setting: MA.17
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
Letrozole sensitizes breast cancer cells to ionizing radiation
The discovery and mechanism of action of letrozole
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
The early days of letrozole
A decade of letrozole: FACE
Letrozole in Male Breast Cancer
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Vitamin K1 pharmacokinetics in a clinical study and VKORC1 enzyme kinetics using HPLC methodology
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
Letrozole in the extended adjuvant setting: MA.17
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
Letrozole sensitizes breast cancer cells to ionizing radiation